In vitro micro-physiological models for translational immunology.

The immune system is a source of regulation of the human body and is key for its stable functioning. Animal models have been successfully used for many years to study human immunity and diseases and provided significant contributions to the development of powerful new therapies. However, such models inevitably display differences from the human metabolism and disease state and therefore may correlate poorly with the human conditions. This explains the interest for the use of in vitro models of human cells, which have better potential to assist in understanding the physiological events that characterize the immune response in humans. Microfluidic technologies offer great capabilities to create miniaturized in vivo-like physiological models that mimic tissue-tissue interactions and simulate the body metabolism in both the healthy and diseased states. The micro-scale features of these microfluidic systems allow positioning heterogeneous cellular cultures in close proximity to each other in a dynamic fluidic environment, thereby allowing efficient cell-cell interactions and effectively narrowing the gap between in vivo and in vitro conditions. Due to the relative simplicity of these systems, compared to animal models, it becomes possible to investigate cell signaling by monitoring the metabolites transported from one tissue to another in real time. This allows studying detailed physiological events and in consequence understanding the influence of metabolites on a specific tissue/organ function as well as on the healthy/diseased state modulation. Numerous in vitro models of human organs have been developed during the last few years, aiming to mimic as closely as possible the in vivo characteristics of such organs. This technology is still in its infancy, but is promised a bright future in industrial and medical applications. Here we review the recent literature, in which functional microphysiological models have been developed to mimic tissues and to explore multi-tissue interactions, focusing in particular on the study of immune reactions, inflammation and the development of diseases. Also, an outlook on the opportunities and issues for further translational development of functional in vitro models in immunology will be presented.

[1]  Marissa Nichole Rylander,et al.  Microfluidic culture models to study the hydrodynamics of tumor progression and therapeutic response , 2013, Biotechnology and bioengineering.

[2]  A. Jayaraman,et al.  Co-culture of epithelial cells and bacteria for investigating host-pathogen interactions. , 2010, Lab on a chip.

[3]  Shih-Siou Wang,et al.  An integrated microfluidic cell culture system for high-throughput perfusion three-dimensional cell culture-based assays: effect of cell culture model on the results of chemosensitivity assays. , 2013, Lab on a chip.

[4]  J. Koistinaho,et al.  Interactions between Alzheimer's disease and cerebral ischemia—focus on inflammation , 2005, Brain Research Reviews.

[5]  G. Zoppo.  Microvascular Responses to Cerebral Ischemia/Inflammation a , 1997 .

[6]  Ana M. Rojas,et al.  The Nod-Like Receptor (NLR) Family: A Tale of Similarities and Differences , 2008, PloS one.

[7]  P. Annaert,et al.  In Vitro Screening Models to Assess Intestinal Drug Absorption and Metabolism , 2008 .

[8]  M. Ponec,et al.  In vitro cultured human skin cells as alternatives to animals for skin irritancy screening , 1992, International journal of cosmetic science.

[9]  N. Elvassore,et al.  Human-on-chip for therapy development and fundamental science. , 2014, Current opinion in biotechnology.

[10]  B. Bao,et al.  Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPKα1/SIRT1[S] , 2014, Journal of Lipid Research.

[11]  Mandy B. Esch,et al.  How multi-organ microdevices can help foster drug development. , 2014, Advanced drug delivery reviews.

[12]  I. Davidson,et al.  Pathogenic obesity and nutraceuticals , 2011, Proceedings of the Nutrition Society.

[13]  H. Schreiber,et al.  Inflammation as a tumor promoter in cancer induction. , 2004, Seminars in cancer biology.

[14]  Tza-Huei Wang,et al.  An open-access microfluidic model for lung-specific functional studies at an air-liquid interface , 2009, Biomedical microdevices.

[15]  Lance L. Munn,et al.  Fluid forces control endothelial sprouting , 2011, Proceedings of the National Academy of Sciences.

[16]  K. Suh,et al.  A multi-layer microfluidic device for efficient culture and analysis of renal tubular cells. , 2010, Lab on a chip.

[17]  John B. Shoven,et al.  I , Edinburgh Medical and Surgical Journal.

[18]  I. Bergheim,et al.  Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease. , 2009, The Journal of nutritional biochemistry.

[19]  David Beebe,et al.  Engineers are from PDMS-land, Biologists are from Polystyrenia. , 2012, Lab on a chip.

[20]  Siglas de Palabras.  a D. g. , 2013 .

[21]  Joseph W Freeman,et al.  3D in vitro bioengineered tumors based on collagen I hydrogels. , 2011, Biomaterials.

[22]  Dong-Hyun Kim,et al.  Lactobacillus plantarum CLP-0611 ameliorates colitis in mice by polarizing M1 to M2-like macrophages. , 2014, International immunopharmacology.

[23]  D. Ingber,et al.  Microfluidic organs-on-chips , 2014, Nature Biotechnology.

[24]  Uwe Marx,et al.  Skin and hair on-a-chip: in vitro skin models versus ex vivo tissue maintenance with dynamic perfusion. , 2013, Lab on a chip.

[25]  P. Mortensen,et al.  Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. , 1995, Gut.

[26]  G. Whitesides,et al.  Rapid Prototyping of Microfluidic Systems in Poly(dimethylsiloxane). , 1998, Analytical chemistry.

[27]  Eli J. Weinberg,et al.  In vitro analysis of a hepatic device with intrinsic microvascular-based channels , 2008, Biomedical microdevices.

[28]  V. Mai,et al.  Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health. , 2009, World journal of gastroenterology.

[29]  D. Thakker,et al.  Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium , 1997 .

[30]  Justin C. Williams,et al.  Microfluidics-based devices: New tools for studying cancer and cancer stem cell migration. , 2011, Biomicrofluidics.

[31]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[32]  G. Dubini,et al.  A novel device to concurrently assess leukocyte extravasation and interstitial migration within a defined 3D environment. , 2015, Lab on a chip.

[33]  P. Artursson.  Cell cultures as models for drug absorption across the intestinal mucosa. , 1991, Critical reviews in therapeutic drug carrier systems.

[34]  A. Margioris,et al.  Fatty acids and postprandial inflammation , 2009, Current opinion in clinical nutrition and metabolic care.

[35]  A. Gebert.  The role of M cells in the protection of mucosal membranes , 1997, Histochemistry and Cell Biology.

[36]  Per Artursson,et al.  Selective Paracellular Permeability in Two Models of Intestinal Absorption: Cultured Monolayers of Human Intestinal Epithelial Cells and Rat Intestinal Segments , 1993, Pharmaceutical Research.

[37]  J. Winn,et al.  Brain , 1878, The Lancet.

[38]  Ericka Stricklin-Parker,et al.  Ann , 2005 .

[39]  T. Shirakawa,et al.  Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. , 2009, FEMS immunology and medical microbiology.

[40]  Tejal A Desai,et al.  Microscale multilayer cocultures for biomimetic blood vessels. , 2005, Journal of biomedical materials research. Part A.

[41]  W. Andlauer,et al.  Modulation of tight junction integrity by food components , 2013 .

[42]  D. Beebe,et al.  The present and future role of microfluidics in biomedical research , 2014, Nature.

[43]  A. Bayat,et al.  Science, medicine, and the future: Bioinformatics. , 2002, BMJ.

[44]  Lauren L Bischel,et al.  Tubeless microfluidic angiogenesis assay with three-dimensional endothelial-lined microvessels. , 2013, Biomaterials.

[45]  Mandy B. Esch,et al.  Characterization of a gastrointestinal tract microscale cell culture analog used to predict drug toxicity , 2009, Biotechnology and bioengineering.

[46]  D. Webb.  Animal models of human disease: inflammation. , 2014, Biochemical pharmacology.

[47]  R. Medzhitov.  Origin and physiological roles of inflammation , 2008, Nature.

[48]  Carsten Goebel,et al.  Assessment of the U937 cell line for the detection of contact allergens. , 2007, Toxicology and applied pharmacology.

[49]  Shuvo Roy,et al.  A microfluidic bioreactor with integrated transepithelial electrical resistance (TEER) measurement electrodes for evaluation of renal epithelial cells , 2010, Biotechnology and bioengineering.

[50]  M. Jepson,et al.  Studying M cells and their role in infection. , 1998, Trends in microbiology.

[51]  G. Paolisso,et al.  Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. , 2002, Journal of the American College of Cardiology.

[52]  O. Guenat,et al.  The potential of microfluidic lung epithelial wounding: towards in vivo-like alveolar microinjuries. , 2014, Integrative biology : quantitative biosciences from nano to macro.

[53]  Ling Yu,et al.  On-chip investigation of cell-drug interactions. , 2013, Advanced drug delivery reviews.

[54]  A. Palmer.  The role of the blood brain barrier in neurodegenerative disorders and their treatment. , 2011, Journal of Alzheimer's disease : JAD.

[55]  Weihua Huang,et al.  Engineering interconnected 3D vascular networks in hydrogels using molded sodium alginate lattice as the sacrificial template. , 2014, Lab on a chip.

[56]  A. Kaur,et al.  The evolution of vertebrate Toll-like receptors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[57]  N. Pradel,et al.  Interactions with M Cells and Macrophages as Key Steps in the Pathogenesis of Enterohemorragic Escherichia coli Infections , 2011, PloS one.

[58]  Mandy B. Esch,et al.  The role of body-on-a-chip devices in drug and toxicity studies. , 2011, Annual review of biomedical engineering.

[59]  C. Starmer,et al.  Na channel kinetics remain stable during perforated-patch recordings. , 1992, The American journal of physiology.

[60]  Nisha S. Sipes,et al.  In vitro and modelling approaches to risk assessment from the U.S. Environmental Protection Agency ToxCast programme. , 2014, Basic & clinical pharmacology & toxicology.

[61]  Marina Marinovich,et al.  NCTC 2544 and IL-18 production: a tool for the identification of contact allergens. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[62]  S. Ostrovidov,et al.  Membrane-Based PDMS Microbioreactor for Perfused 3D Primary Rat Hepatocyte Cultures , 2004, Biomedical microdevices.

[63]  A. Jarry,et al.  Stimulation of mucin exocytosis from human epithelial cells by nitric oxide: evidence for a cGMP-dependent and a cGMP-independent pathway. , 1997, The Biochemical journal.

[64]  Yves-Jacques Schneider,et al.  An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[65]  C. Dai,et al.  VSL#3 probiotics regulate the intestinal epithelial barrier in vivo and in vitro via the p38 and ERK signaling pathways. , 2011, International journal of molecular medicine.

[66]  R. Owen.  Sequential uptake of horseradish peroxidase by lymphoid follicle epithelium of Peyer's patches in the normal unobstructed mouse intestine: an ultrastructural study. , 1977, Gastroenterology.

[67]  Ronald H. Zielke,et al.  Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[68]  Uwe Marx,et al.  Immunological substance testing on human lymphatic micro-organoids in vitro. , 2010, Journal of biotechnology.

[69]  S. Stavchansky,et al.  Estimation of the Relative Contribution of the Transcellular and Paracellular Pathway to the Transport of Passively Absorbed Drugs in the Caco-2 Cell Culture Model , 1997, Pharmaceutical Research.

[70]  J. Synowiecki,et al.  Chemical nature of xanthophylls in flesh and skin of cultured Arctic char (Salvelinus alpinus L.) , 1994 .

[71]  J. Madara,et al.  Rapid barrier restitution in an in vitro model of intestinal epithelial injury. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[72]  S. Bolz,et al.  A microfluidic platform for probing small artery structure and function. , 2010, Lab on a chip.

[73]  Shuichi Takayama,et al.  Acoustically detectable cellular-level lung injury induced by fluid mechanical stresses in microfluidic airway systems , 2007, Proceedings of the National Academy of Sciences.

[74]  Tal Dvir,et al.  Nanotechnological strategies for engineering complex tissues. , 2020, Nature nanotechnology.

[75]  Seung Choi,et al.  ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? J ? ? J ? ? ? ? ? ? ? ? ? ? ? ? ? ? , 2022 .

[76]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[77]  M. Carroll,et al.  Linkages of innate and adaptive immunity. , 1998, Current opinion in immunology.

[78]  Aaron Sin,et al.  Development of a Microscale Cell Culture Analog To Probe Naphthalene Toxicity , 2008, Biotechnology progress.

[79]  R. Gay,et al.  The living skin equivalent as a model in vitro for ranking the toxic potential of dermal irritants. , 1992, Toxicology in vitro : an international journal published in association with BIBRA.

[80]  R. Nelson,et al.  Inflammation: Mechanisms, Costs, and Natural Variation , 2012 .

[81]  Jiajie Yu,et al.  On chip porous polymer membranes for integration of gastrointestinal tract epithelium with microfluidic ‘body-on-a-chip’ devices , 2012, Biomedical microdevices.

[82]  J. Qin,et al.  Biomimetic tumor microenvironment on a microfluidic platform. , 2013, Biomicrofluidics.

[83]  C. Goebel,et al.  Characterization of the sensitizing potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration. , 2004, The Journal of investigative dermatology.

[84]  Uwe Marx,et al.  Human immunity in vitro - solving immunogenicity and more. , 2014, Advanced drug delivery reviews.

[85]  S. Bischoff,et al.  'Gut health': a new objective in medicine? , 2011, BMC medicine.

[86]  V. Mai,et al.  Colonic bacterial flora: changing understandings in the molecular age. , 2004, The Journal of nutrition.

[87]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[88]  Y. Apidianakis,et al.  Regenerative Inflammation: Lessons from Drosophila Intestinal Epithelium in Health and Disease , 2013, Pathogens.

[89]  J. DiMasi,et al.  The cost of biopharmaceutical R&D: is biotech different? , 2007 .

[90]  Xin Zhang,et al.  Topographically-patterned porous membranes in a microfluidic device as an in vitro model of renal reabsorptive barriers. , 2013, Lab on a chip.

[91]  Hiroshi Itagaki,et al.  The in vitro skin sensitization test; human cell line activation test (h-CLAT) using THP-1 cells , 2007 .

[92]  Michael L. Shuler,et al.  Growth of endothelial cells on microfabricated silicon nitride membranes for anin vitro model of the blood-brain barrier , 2003 .

[93]  D. Beebe,et al.  PDMS absorption of small molecules and consequences in microfluidic applications. , 2006, Lab on a chip.

[94]  H. J. Kolmos,et al.  Escherichia coli Uropathogenesis In Vitro: Invasion, Cellular Escape, and Secondary Infection Analyzed in a Human Bladder Cell Infection Model , 2012, Infection and Immunity.

[95]  C. Janeway,et al.  The immune system evolved to discriminate infectious nonself from noninfectious self. , 1992, Immunology today.

[96]  M. Neutra,et al.  Human Intestinal M Cells Display the Sialyl Lewis A Antigen , 1999, Infection and Immunity.

[97]  L. Akinbami,et al.  Trends in childhood asthma: prevalence, health care utilization, and mortality. , 2002, Pediatrics.

[98]  D. Ye,et al.  Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[99]  Ling Qi,et al.  Mechanisms of inflammatory responses in obese adipose tissue. , 2012, Annual review of nutrition.

[100]  G Frank Gerberick,et al.  Development of a peptide reactivity assay for screening contact allergens. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[101]  Allan Linneberg,et al.  The epidemiology of contact allergy in the general population – prevalence and main findings , 2007, Contact dermatitis.

[102]  Y. Schneider,et al.  Iron absorption by intestinal epithelial cells: 1. CaCo2 cells cultivated in serum-free medium, on polyethyleneterephthalate microporous membranes, as an in vitro model , 1991, In Vitro Cellular & Developmental Biology - Animal.

[103]  Alessio Fasano,et al.  Mechanisms of Disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases , 2005, Nature Clinical Practice Gastroenterology &Hepatology.

[104]  D. Ingber,et al.  Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. , 2012, Lab on a chip.

[105]  Michael Karin,et al.  NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.

[106]  J. Moake,et al.  In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. , 2012, The Journal of clinical investigation.

[107]  M. Kamm,et al.  Microbial-gut interactions in health and disease. Interactions between dendritic cells and bacteria in the regulation of intestinal immunity. , 2004, Best practice & research. Clinical gastroenterology.

[108]  K. Ley,et al.  Immune and inflammatory mechanisms of atherosclerosis (*). , 2009, Annual review of immunology.

[109]  R. Kamm,et al.  Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function , 2012, Proceedings of the National Academy of Sciences.

[110]  Mandy B. Esch,et al.  Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury. , 2014, Lab on a chip.

[111]  A. Berg,et al.  BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function , 2013, Biomedical microdevices.

[112]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[113]  C. Wijmenga,et al.  Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitisAn unusual case of ascites , 2007, Gut.

[114]  A. Goldfine,et al.  Inflammation and insulin resistance. , 2006, The Journal of clinical investigation.

[115]  T. Luger,et al.  Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light , 1990, The Journal of experimental medicine.

[116]  Ali Keshavarzian,et al.  Intestinal Permeation and Gastrointestinal Disease , 2002, Journal of clinical gastroenterology.

[117]  E. Wherry,et al.  Commensal bacteria calibrate the activation threshold of innate antiviral immunity. , 2012, Immunity.

[118]  Sonia Grego,et al.  A biomimetic multicellular model of the airways using primary human cells. , 2014, Lab on a chip.

[119]  Roger D Kamm,et al.  Validating antimetastatic effects of natural products in an engineered microfluidic platform mimicking tumor microenvironment. , 2014, Molecular pharmaceutics.

[120]  M. Sefton,et al.  Hepatic organoids for microfluidic drug screening. , 2014, Lab on a chip.

[121]  N. K. Jerne,et al.  The immune system. , 1973, Scientific American.

[122]  H. Sell,et al.  Adaptive immunity in obesity and insulin resistance , 2012, Nature Reviews Endocrinology.

[123]  G. Courtois,et al.  TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2 , 2002, Nature.

[124]  J. Clària,et al.  New Insights into the Role of Macrophages in Adipose Tissue Inflammation and Fatty Liver Disease: Modulation by Endogenous Omega-3 Fatty Acid-Derived Lipid Mediators , 2011, Front. Immun..

[125]  Luke P. Lee,et al.  Physiologically relevant organs on chips , 2014, Biotechnology journal.

[126]  Mauro Biffoni,et al.  Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells , 2011, Nature.

[127]  Dora Brites,et al.  Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches , 2010, Brain Research Reviews.

[128]  M. Corada,et al.  The molecular basis of the blood brain barrier differentiation and maintenance. Is it still a mystery? , 2011, Pharmacological research.

[129]  Hanseup Kim,et al.  Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). , 2012, Lab on a chip.

[130]  J. Travis.  Origins. On the origin of the immune system. , 2009, Science.

[131]  J. Kraehenbuhl,et al.  Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. , 1997, Science.

[132]  David J Brayden,et al.  Expression of specific markers and particle transport in a new human intestinal M-cell model. , 2000, Biochemical and biophysical research communications.

[133]  G. Biondi-Zoccai,et al.  Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. , 2004, European Journal of Cardio-Thoracic Surgery.

[134]  L. Griffith,et al.  Bioreactor technologies to support liver function in vitro. , 2014, Advanced drug delivery reviews.

[135]  D. Janigro,et al.  A Dynamic in vitro BBB Model for the Study of Immune Cell Trafficking into the Central Nervous System , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[136]  R. Steinman,et al.  Dendritic cells: translating innate to adaptive immunity. , 2006, Current topics in microbiology and immunology.

[137]  C. Janeway,et al.  Innate Immunity: The Virtues of a Nonclonal System of Recognition , 1997, Cell.

[138]  L. Etienne-Mesmin,et al.  Relevance and challenges in modeling human gastric and small intestinal digestion. , 2012, Trends in biotechnology.

[139]  Teruo Fujii,et al.  Microfluidic PDMS (Polydimethylsiloxane) Bioreactor for Large‐Scale Culture of Hepatocytes , 2004, Biotechnology progress.

[140]  Mohammad Wahid Ansari,et al.  The legal status of in vitro embryos , 2014 .

[141]  S. Hogan,et al.  Intestinal barrier function: molecular regulation and disease pathogenesis. , 2009, The Journal of allergy and clinical immunology.

[142]  Jong Hwan Sung,et al.  A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs. , 2009, Lab on a chip.

[143]  K. Herold,et al.  Humanized Mice as a Model for Aberrant Responses in Human T Cell Immunotherapy , 2014, The Journal of Immunology.

[144]  Thomas Hartung,et al.  Chemical regulators have overreached , 2009, Nature.

[145]  P. Grammas,et al.  Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases , 2011, Expert Reviews in Molecular Medicine.

[146]  G. Schmid-Schönbein,et al.  Analysis of inflammation. , 2006, Annual review of biomedical engineering.

[147]  Roger D Kamm,et al.  A versatile assay for monitoring in vivo-like transendothelial migration of neutrophils. , 2012, Lab on a chip.

[148]  I. Bernstein,et al.  Contact dermatitis: a practice parameter , 2006 .

[149]  Qingjun Liu,et al.  A novel microphysiometer based on high sensitivity LAPS and microfluidic system for cellular metabolism study and rapid drug screening. , 2013, Biosensors & bioelectronics.

[150]  C. Parish,et al.  Dependence of the adaptive immune response on innate immunity: Some questions answered but new paradoxes emerge , 1997, Immunology and cell biology.

[151]  Myeong Soo Lee,et al.  Inflammation‐mediated obesity and insulin resistance as targets for nutraceuticals , 2011, Annals of the New York Academy of Sciences.

[152]  Gang Wang,et al.  Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies , 2014 .

[153]  J. Schulzke,et al.  Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications , 2007, Current opinion in gastroenterology.

[154]  H. Kimura,et al.  An integrated microfluidic system for long-term perfusion culture and on-line monitoring of intestinal tissue models. , 2008, Lab on a chip.

[155]  William Shain,et al.  An endothelial and astrocyte co-culture model of the blood-brain barrier utilizing an ultra-thin, nanofabricated silicon nitride membrane. , 2005, Lab on a chip.

[156]  D. Ingber,et al.  From 3D cell culture to organs-on-chips. , 2011, Trends in cell biology.

[157]  Kevin Kit Parker,et al.  Human airway musculature on a chip: an in vitro model of allergic asthmatic bronchoconstriction and bronchodilation. , 2014, Lab on a chip.

[158]  Rong Wang,et al.  Glioblastoma stem-like cells give rise to tumour endothelium , 2010, Nature.

[159]  I. Verma,et al.  Inflammation-associated cancer: NF-κB is the lynchpin , 2005 .

[160]  D. Beebe,et al.  Biological implications of polydimethylsiloxane-based microfluidic cell culture. , 2009, Lab on a chip.

[161]  D. Beebe,et al.  Cell culture models in microfluidic systems. , 2008, Annual review of analytical chemistry.

[162]  Laurent Griscom,et al.  Development of a Renal Microchip for In Vitro Distal Tubule Models , 2007, Biotechnology progress.

[163]  Brendon M. Baker,et al.  Rapid casting of patterned vascular networks for perfusable engineered 3D tissues , 2012, Nature materials.

[164]  M. Neurath,et al.  Epithelial NEMO links innate immunity to chronic intestinal inflammation , 2007, Nature.

[165]  W. Marsden.  I and J , 2012 .

[166]  R Roguet,et al.  A prevalidation study on in vitro tests for acute skin irritation. results and evaluation by the Management Team. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[167]  Mandy B. Esch,et al.  Oral exposure to polystyrene nanoparticles affects iron absorption. , 2012, Nature nanotechnology.

[168]  Shuichi Takayama,et al.  Microfluidic Endothelium for Studying the Intravascular Adhesion of Metastatic Breast Cancer Cells , 2009, PloS one.

[169]  R. Kamm,et al.  In Vitro Model of Tumor Cell Extravasation , 2013, PloS one.

[170]  T. Tada.  The immune system as a supersystem. , 1997, Annual review of immunology.

[171]  Teruo Fujii,et al.  Perfusion culture of fetal human hepatocytes in microfluidic environments , 2004 .

[172]  N. Wong,et al.  An immunohistochemical study and review of potential markers of human intestinal M cells. , 2009, European journal of histochemistry : EJH.

[173]  T. Miyakawa,et al.  Genomic responses in mouse models poorly mimic human inflammatory diseases , 2013 .

[174]  Laurent Griscom,et al.  Improvement of HepG2/C3a cell functions in a microfluidic biochip , 2011, Biotechnology and bioengineering.

[175]  D. Ingber,et al.  Reconstituting Organ-Level Lung Functions on a Chip , 2010, Science.

[176]  C. Colaco,et al.  Acquired wisdom in innate immunity. , 1998, Immunology today.

[177]  M. Gribaudo,et al.  2002 , 2001, Cell and Tissue Research.

[178]  J. Welter,et al.  Combined Experimental and Mathematical Approach for Development of Microfabrication-Based Cancer Migration Assay , 2011, Annals of Biomedical Engineering.

[179]  Gwo-Bin Lee,et al.  Microfluidic cell culture systems for drug research. , 2010, Lab on a chip.

[180]  C. Nicoletti,et al.  Unsolved mysteries of intestinal M cells , 2000, Gut.

[181]  Sandro Carrara,et al.  NutriChip: nutrition analysis meets microfluidics. , 2013, Lab on a chip.

[182]  David A Basketter,et al.  In vitro skin irritation: facts and future. State of the art review of mechanisms and models. , 2004, Toxicology in vitro : an international journal published in association with BIBRA.

[183]  Nicola J Cooper,et al.  Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[184]  Emanuela Corsini,et al.  Transfer of a two-tiered keratinocyte assay: IL-18 production by NCTC2544 to determine the skin sensitizing capacity and epidermal equivalent assay to determine sensitizer potency. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[185]  G. Schmid-Schönbein,et al.  The Inflammatory Aspect of the Microcirculation in Hypertension: Oxidative Stress, Leukocytes/Endothelial Interaction, Apoptosis , 2002, Microcirculation.

[186]  Dong Yun Lee,et al.  Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells. , 2014, Biomaterials.

[187]  G. Schmid-Schönbein,et al.  A New Hypothesis for Microvascular Inflammation in Shock and Multiorgan Failure: Self‐Digestion by Pancreatic Enzymes , 2005, Microcirculation.

[188]  J. Cooper,et al.  Tumors on chips: oncology meets microfluidics. , 2010, Current opinion in chemical biology.

[189]  Wei Wang,et al.  Live human nasal epithelial cells (hNECs) on chip for in vitro testing of gaseous formaldehyde toxicity via airway delivery. , 2014, Lab on a chip.

[190]  Donald E Ingber,et al.  Can cancer be reversed by engineering the tumor microenvironment? , 2008, Seminars in cancer biology.

[191]  P. Artursson,et al.  Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[192]  M K Robinson,et al.  Comparison of in vitro and in vivo human skin responses to consumer products and ingredients with a range of irritancy potential. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[193]  R. Mrsny,et al.  A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. , 2002, Gastroenterology.

[194]  Yordan Kostov,et al.  The Design and Fabrication of Three‐Chamber Microscale Cell Culture Analog Devices with Integrated Dissolved Oxygen Sensors , 2008, Biotechnology progress.

[195]  D. Mcclements,et al.  In vitro human digestion models for food applications , 2011 .